Does Being Fit Protect Against VTE? – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Haofeng Zhou et al․, adding:
“Does being fit protect against venous thromboembolism?
Venous thromboembolism (VTE) is a leading cardiovascular disease with a substantial burden, yet the link between cardiorespiratory fitness (CRF) and VTE risk has remained inconclusive. A new cohort study in RPTH Journal uses UK Biobank data to investigate.
Key findings from 63,755 participants without prior VTE (median follow-up 12.5 years; 1,744 incident VTE cases):
- Each 1-MET increment in CRF was associated with an 8% lower VTE risk (HR 0.92; 95% CI 0.89–0.95)
- High CRF vs low CRF: 27% lower risk of VTE (HR 0.73; 95% CI 0.63–0.84)
- The inverse association was observed across all genetic risk strata, including people with high polygenic risk
- Inflammation (CRP), hepatobiliary enzymes and renal markers (cystatin C, creatinine) together explained about 21.5% of the association
The message is encouraging: higher cardiorespiratory fitness is associated with lower VTE risk regardless of genetic susceptibility, and part of this benefit may run through lower inflammation and better liver and kidney health.”
Title: Association between cardiorespiratory fitness and risk of incident venous thromboembolism: a prospective cohort study
Authors: Haofeng Zhou, Ruisheng Zhang, Zhongxing Jiang, Ying Guo, Lan Guo, Haopeng Ke, Kaixuan Lin, Fang Wang

More posts featuring RPTH Journal on Hemostasis Today.
-
Nov 20, 2026, 12:29Thirunavukkarasu Angappan: Antithrombin in ECMO – Two Datasets, Two Opposite Answers
-
Nov 20, 2026, 11:38Muhammad Kashif: Therapeutic Plasma Exchange – Key Concepts at a Glance
-
Nov 20, 2026, 11:33Tyler McConville: Why Hemostatic Function Matters More Than Cell Counts in Trauma and Transfusion
-
Nov 20, 2026, 11:28Stéphanie Forté: Bringing Cutting-Edge Genomic and Proteomic Tools to Sickle Cell Disease Patients
-
Nov 20, 2026, 11:19EHC Urges Equal Early Diagnosis for Bleeding Disorders
-
Nov 20, 2026, 11:14Pushpinder Singh: How Do We Know if Haemodialysis is Effective?
-
Nov 20, 2026, 11:09Neel Patel: Honoured to Serve Across Five Faculty Roles at Hematocon 2026
-
Nov 20, 2026, 11:03Alok Khorana: First FXI Inhibitor Approved in the US
-
Nov 20, 2026, 06:51How YERM Shapes the Careers of Future Hematology Researchers – EHA